HUMA
Humacyte
$0.67
+$0.05 (+7.84%)Jul 27, 2026
Key metrics
The numbers that frame HUMA today
- Market cap
- $149.64M
- P/E (TTM)
- -1.5
- EV / FCF
- -1.6
- Gross margin
- -475%
- EV / Sales
- 82.7
- ROIC
- -80.3%
- Div yield
- 0%
- Debt / equity
- 5.7
- 52wk Low
- $0.55
- 52wk High
- $2.76
Growth
Revenue and earnings trend for HUMA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about HUMA
Is Humacyte a good buy?
No. Humacyte has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Humacyte is selling at a very high price.
What is the market capitalization of HUMA?
Humacyte's market capitalization is $149.64M.
What is the P/E ratio for HUMA stock?
Humacyte's current P/E ratio is -1.5.
What is the 52-week high for HUMA stock?
The 52-week high for Humacyte is $2.76. The current close of $0.67 is 75.5% below that high.
What is the 52-week low for HUMA stock?
The 52-week low for Humacyte is $0.55. The current close of $0.67 is 23.2% above that low.
Does HUMA stock pay dividends?
Humacyte does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for HUMA?
Humacyte's Debt / Equity ratio is 5.67.